Informations:
Erreur:
ID
22306
Description
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00554515
Lien
https://clinicaltrials.gov/show/NCT00554515
Mots-clés
Versions (1)
- 29/05/2017 29/05/2017 -
Téléchargé le
29 mai 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
- StudyEvent: Eligibility
Similar models
Eligibility Metastatic Renal Cell Carcinoma NCT00554515
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
histologically confirmed renal cell carcinoma, metastatic or unresectable
Item
patients must have histologically confirmed renal cell carcinoma that is metastatic or unresectable.
boolean
C0007134 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,3])
C1336869 (UMLS CUI [1,4])
C0679557 (UMLS CUI [1,2])
C2939420 (UMLS CUI [1,3])
C1336869 (UMLS CUI [1,4])
measurable disease, solitary mass, cytology/histology
Item
if patients have measurable disease restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.
boolean
C1513041 (UMLS CUI [1,1])
C1265601 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0010819 (UMLS CUI [1,4])
C1265601 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,3])
C0010819 (UMLS CUI [1,4])
tissue block
Item
patients must provide access to tissue blocks containing adequate tumor for interpretation and analysis.
boolean
C2316369 (UMLS CUI [1,1])
C2317347 (UMLS CUI [1,2])
C2317347 (UMLS CUI [1,2])
measurable disease
Item
patients must have measurable disease.
boolean
C1513041 (UMLS CUI [1])
ecog, karnofsky
Item
patients must have good performance status (ecog 0 or 1; karnofsky ps 100-80%).
boolean
C1520224 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
C0206065 (UMLS CUI [2])
organ function
Item
patients must have adequate organ function.
boolean
C0678852 (UMLS CUI [1])
contraindication vasopressor agents
Item
patients must have no contraindication of vasopressor agents.
boolean
C1301624 (UMLS CUI [1,1])
C0042397 (UMLS CUI [1,2])
C0042397 (UMLS CUI [1,2])
age
Item
patients must be ≥ 18 years of age.
boolean
C0001779 (UMLS CUI [1])
prior chemotherapy
Item
patients who have received systemic therapy for metastatic disease.
boolean
C1514457 (UMLS CUI [1])
organ allografts
Item
patients with organ allografts.
boolean
C1515895 (UMLS CUI [1,1])
C0524930 (UMLS CUI [1,2])
C0524930 (UMLS CUI [1,2])
systemic corticosteroid therapy
Item
patients who require or are likely to require systemic corticosteroid therapy for intercurrent illness.
boolean
C4053960 (UMLS CUI [1])
comorbidity, risk, immunotherapy
Item
patients with any significant medical disease other than the malignancy (e.g. copd, patients with ascites or pleural effusions), which in the opinion of the investigator would significantly increase the risk of immunotherapy.
boolean
C0009488 (UMLS CUI [1,1])
C0035647 (UMLS CUI [1,2])
C0021083 (UMLS CUI [1,3])
C0035647 (UMLS CUI [1,2])
C0021083 (UMLS CUI [1,3])
history of malignant disease other than surgically cured non-melanoma skin cancer, carcinoma-in-situ or stage i carcinoma of the cervix
Item
patients with a history of another malignancy within the past 5 years other than surgically cured non-melanoma skin cancer, carcinoma-in-situ or stage i carcinoma of the cervix.
boolean
C0455471 (UMLS CUI [1])
C0007114 (UMLS CUI [2,1])
C0332644 (UMLS CUI [2,2])
C0851140 (UMLS CUI [3])
C0278575 (UMLS CUI [4])
C0007114 (UMLS CUI [2,1])
C0332644 (UMLS CUI [2,2])
C0851140 (UMLS CUI [3])
C0278575 (UMLS CUI [4])